Best Stock Report – Penny Stock Newsletter Tracking

Special Report ….

Financial Success That Is More Than Skin-Deep
For the full special report, CLICK HERE.
Companies mentioned in this e-mail include:
avVaa World Health Care Products Inc. – (PINK SHEETS:AVVH),
Isotechnika Inc. – (TSX:ISA)
Provectus Pharmaceuticals Inc. – (OTCBB:PVCT).
Southpeak Interactive Corp. – (OTCBB:SOPK).

LATEST NEWS RELEASE ON AVVAA WORLD HEALTH CARE PRODUCTS INC.
avVaa World Health Care Products, Inc. Announces Agreement with National Telemarketing Company
avVaa World Health Care Products Inc., a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the signing of an agreement with a national Telemarketing Company, Synergixx L.L.C. (“Synergixx”) for all inbound telemarketing.

Telemarketing:
- Open 24 hours/ 7 days a week
- 40% close rate – 35% cross sales rates
- Courteous customer care representatives
- Creative solutions to complicated campaigns

Synergixx utilizes their in-house ASK(TM) system, which empowers telephone
representatives to sell with minimum product knowledge and maximum results,
this means that Synergixx can test new promotions more effectively, create new
offers and packages more consistently and all while closing at a
higher-than-industry-average rate every time. Synergixx telemarketing clients
benefit from:

- 250 reps
- 100 seat call center
- Accurate daily activity reporting
- Real time data entry department 24/7
- Creative solutions to complicated campaign problems
- Phone representatives educated through product and sales training
classes
Charlie Fusco President of Synergixx LLC stated, “There is no sales medium in the world – not TV, Radio, Print, or the Internet – more powerful than a real person who truly believes in a product. With our Instant Experts you can maximize your impact at conventions, trade shows and on TV. Our Instant Experts represent your product or service with enthusiasm, an intimate knowledge base and the directive to sell. It’s the fastest way to develop a quality sales force quickly and affordably.”

avVaa World Health Care has everything in place for launch. “We now have our Media Funding, Media Buying, Fulfillment & Customer Service and Telemarketing,” states Lorie Campbell-Farley, President / COO. “We have come a long way, and now everything in place for the launch, we are very excited, and look forward to the launch,” stated Ms. Farley.
View More
SPECIAL OVERVIEW
Canadian stocks endured a fourth straight finish in the red Wednesday. Resource stocks are struggling on the day, contributing to the weakness. The S&P/TSX Composite Index lost 240.14 points or 2.3 % to finish the day at 10,067.26, its lowest finish in more than three weeks.

In New York, the Nasdaq composite index gained Wednesday, thanks to a tech rally, but the broader market meandered, with financials sliding after Standard & Poor’s cut its outlook on 22 banks. The Dow Jones Industrials average was off 7.49 points to end the day at 8,497.18. The S&P 500 index slid 1.26 points to 910.71. The Nasdaq was up 11.88 points to 1,808.06.
While the broad markets struggled, avVaa World Health Care Products Inc. (PINK SHEETS:AVVH) has now been on a two day rally and gained 40% today alone. The Company might continue to see price appreciation due to an after the bell significant announcement releases today as well as a strong technical reading signalling that the bulls are in control of the stock for the time being.
Another Company that recently came across our desk is Southpeak Interactive Corp. (OTCBB:SOPK). The Company announced last night the release of an in-depth initiation report by Patrick Murphy, CFA, principal of fee-based independent research firm Murphy Analytics. Mr. Murphy expects SouthPeak will deliver significant growth in fiscal 2010 due to its strong pipeline of highly-anticipated titles, and initiated coverage with a 12-month price target of $3.00 per share. SouthPeak Interactive Corporation develops and publishes interactive entertainment software for all current hardware platforms including: PLAYSTATION®3 computer entertainment system, PSP® (PlayStation® Portable) system, PlayStation®2 computer entertainment system, Xbox 360® videogame and entertainment system, Wii™, Nintendo DS™ and PC. SouthPeak’s products are sold in retail outlets in North America, Europe, Australia and Asia. We will continue to watch SOPK and should have more information on the Company for our readers soon.
But today’s major development continues to be AVVH, we encourage investors to keep a close eye on the Company during tomorrow’s trading session.
ALLPENNYSTOCKS.COM NEWS ARTICLE
June 17, 2009 (AllPennyStocks.com Media, Inc.) – It’s hardly up there on the list of health matters occupying the world stage these days – surely, not in light of the current flu pandemic – but psoriasis (pronounced sor-EYE-ah-sis) is a chronic disease that affects the skin and joints, causing red, scaly patches to appear on the skin. While it’s not known that psoriasis kills, it often curbs the quality of life to the point where its sufferers become acutely depressed and socially isolated. According to the National Institutes of Health, as many as 7.5 million Americans have psoriasis.

A recent study out of Miami also showed that psoriasis could pose cardiovascular risks. The study, conducted on those of average age in their upper 60s, found psoriasis patients were particularly likely to have diabetes, high blood pressure and poor cholesterol profiles. Those conditions make cardiovascular problems more likely.

To date, there is no cure and methods to treat the disorder range from home remedies to creams offered by various companies over the Internet – detox teas, sea cucumber, shark liver oils, skin creams and shampoos. Major drug and cosmetic companies have shied away from developing the means to fight psoriasis.

The leading health-related organizations in the U.S. specializing in skin problems have indicated that the estimated 40 million U.S. consumers spend $4 Billion U.S. each year on over-the-counter products to ease their reoccurring pain and discomfort.
Click here for the full report.
OVERVIEW
avVaa World Health Care Products, Inc. was formed to manage the manufacturing, distribution, sales and marketing of health care products throughout the world. avVaa has obtained from the German inventor the manufacturing, distribution, sales and marketing rights for products that control specific skin disorders, including eczema, psoriasis, acne, dermatitis and other types of skin conditions. The management team, under the direction of its Chairman and CEO, Jack Farley, has defined and directed the Company’s focus on the natural skin care product line. The direction of the Corporation has been to focus on North and South American opportunities directly relating to its skin care product line, with rapid expansion planned for the rest of the world after initial product launch in the Americas.
For more information on avVaa World Health Care Products, Inc., CLICK HERE.
Isotechnika Inc. is a biopharmaceutical company focused on the discovery and development of novel immunosuppressive therapeutics that are designed to offer advantages over other currently available treatments. There is a significant unmet medical need in the treatment of both solid organ transplantation and autoimmune disease. It is estimated that the market potential will exceed $4 billion annually in sales for calcineurin inhibitors such as voclosporin by 2010. Voclosporin is a next generation calcineurin inhibitor, which completed a Phase 2b North American trial for the prevention of kidney rejection following transplantation. Extensions to the Phase 2b trial and a combined Phase 3 European/Canadian trial for the treatment of moderate to severe psoriasis have also been completed.
For more information on Isotechnika Inc., CLICK HERE.
Provectus Pharmaceuticals, Inc. is a development stage company that specializes in oncology and dermatology therapies that are safer, more effective, less invasive and more economical than conventional therapies. Provectus is currently conducting Phase 2 clinical trials of its proprietary drugs PV-10 as a therapy for metastatic melanoma and PH-10 as a topical treatment for psoriasis and atopic dermatitis. Information about these and the Company’s other clinical trials can be found at the NIH registry, www.clinicaltrials.gov. The Company has received orphan drug designation from the FDA for its melanoma indication. Complementing their suite of proprietary drugs, Provectus has developed a number of intellectual properties and technologies in the areas of imaging, medical devices and biotechnology.
For more information on Provectus Pharmaceuticals, Inc., CLICK HERE.
SouthPeak Interactive Corp. develops and publishes interactive entertainment software for all current hardware platforms including: PLAYSTATION®3 computer entertainment system, PSP® (PlayStation® Portable) system, PlayStation®2 computer entertainment system, Xbox 360® videogame and entertainment system, Wii™, Nintendo DS™ and PC. SouthPeak’s games cover all major genres including action/adventure, role playing, racing, puzzle strategy, fighting and combat. SouthPeak’s products are sold in retail outlets in North America, Europe, Australia and Asia. SouthPeak is headquartered in Midlothian, Virginia, and has offices in Grapevine, Texas and Leicester, England.
For more information on SouthPeak Interactive Corp., CLICK HERE.

Forward Looking Statements
This report includes forward-looking statements that reflect the mentioned companies current expectations about its future results, performance, prospects and opportunities. the mentioned companies has tried to identify these forward-looking statements by using words and phrases such as “may,” “will,” “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plan,” “should,” “typical,” “preliminary,” “we are confident” or similar expressions. These forward-looking statements are based on information currently available and are subject to a number of risks, uncertainties and other factors that could cause the mentioned companies actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. These risks, uncertainties and other factors include, without limitation, the Company’s growth expectations and ongoing funding requirements, and specifically, the Company’s growth prospects with scalable customers, and those outlined above. Other risks include the Company’s limited operating history, the Company’s history of operating losses, consumers’ acceptance, the Company’s use of licensed technologies, risk of increased competition, the potential need for additional financing, the terms and conditions of any financing that is consummated, the limited trading market for the Company’s securities, the possible volatility of the Company’s stock price, the concentration of ownership, and the potential fluctuation in the Company’s operating results.
Disclaimer
AllPennyStocks.com feature stock reports are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this report was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. For more information see our disclaimer section, a link of which can be found on our web site. This document contains forward-looking statements, particularly as related to the business plans of the Company, within the meaning of Section 27A of the Securities Act of 1933 and Sections 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created by these sections. Actual results may differ materially from the Company’s expectations and estimates. This is an advertisement for the mentioned companies The purpose of this advertisement, like any advertising, is to provide coverage and awareness for the company. The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country.
© 1999-2009 AllPennyStocks.com. All rights reserved. AllPennyStocks.com is not a Registered Broker/Dealer or Financial Advisor, nor do we hold ourselves out to be. All materials presented on our web site and individual reports released to the public through this web site, e-mail or any other means of transmission are not to be regarded as investment advice and are only for informative purposes. Before making a purchase or sale of any securities featured on our web site or mentioned in our reports, we strongly encourage and recommend consultation with a registered securities representative. This is not to be construed as a solicitation or recommendation to buy or sell securities. As with any stock, companies we select to profile involve a degree of investment risk and volatility. Particularly Small-Caps and OTC-BB stocks. All investors are cautioned that they may lose all or a portion of their investment if they decide to make a purchase in any of our profiled companies. Past performance of our profiled stocks is not indicative of future results. The accuracy or completeness of the information on our web site or within our reports is only as reliable as the sources they were obtained from. The profile and opinions expressed herein are expressed as of the date the profile is posted on site and are subject to change without notice. No investor should assume that reliance on the views; opinions or recommendations contained herein will produce profitable results. AllPennyStocks.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our web site or within our reports. In order to be in full compliance with the Securities Act of 1933, Section 17(b), AllPennyStocks.com will disclose in it’s disclaimer, what, if any compensation was received for our efforts in researching, presenting and disseminating this information to our subscriber database and featuring the report on the AllPennyStocks.com web site. AllPennyStocks.com has been compensated sixty eight Million rule-144 shares by the company for its efforts in presenting the AVVH profile on its web site and distributing it to its database of subscribers as well as other services. AllPennyStocks.com may decide to purchase or sell shares on a voluntary basis in the open market before, during or after the profiling period of this report. As of the profile date, no shares have been sold. Information presented on our web site and within our reports contain “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be “forward looking statements.” Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as “expects”, “will,” “anticipates,” “estimates, “believes,” or that by statements indicating certain actions “may,” “could,” or “might” occur.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SMALL CAP SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission (SEC) at: http://www.sec.gov and/or the National Association of Securities Dealers (NASD) at: http://www.nasd.com. Readers can review all public filings by companies at the SEC’s EDGAR page. The NASD has published information on how to invest carefully at its web site.